Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) by conjunctival cells

被引:53
作者
Chen, L [1 ]
Cursiefen, C [1 ]
Barabino, S [1 ]
Zhang, Q [1 ]
Dana, MR [1 ]
机构
[1] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol,Schepens Eye Res Inst,Lab Immunol, Boston, MA 02114 USA
关键词
D O I
10.1167/iovs.05-0975
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Lymphatic vessel endothelial hyaluronic acid receptor (LYVE-1) is a newly discovered lymphatic-specific marker. To date, there is no report of its expression on conjunctival cells. The purpose of this study was to investigate the expression of LYVE-1 in normal conjunctiva, to phenotype LYVE-1(+) cells, and to study changes in their expression levels during corneal inflammation. METHODS. Flatmounted conjunctivae or cross sections of eyeballs were harvested from BALB/c mice (6-8 weeks of age) for immunofluorescent confocal microscopic studies. RESULTS. The data demonstrate, for the first time, that in addition to its expression on lymphatic vessels, LYVE-1 was expressed on CD45(+), CD11b(+), and CD31(-) conjunctival cells, indicating a bone-marrow-derived monocytic lineage. Surprisingly, the number of cells that expressed LYVE-1 decreased during corneal inflammation, in conjunction with ingrowth of lymphatics into the cornea. CONCLUSIONS. A new population of monocytic cells has been found to express LYVE-1 in normal conjunctiva. These cells that normally express LYVE-1 may act as a reservoir for lymphangiogenesis and cell recruitment when the immune system is challenged.
引用
收藏
页码:4536 / 4540
页数:5
相关论文
共 22 条
[1]   LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan [J].
Banerji, S ;
Ni, J ;
Wang, SX ;
Clasper, S ;
Su, J ;
Tammi, R ;
Jones, M ;
Jackson, DG .
JOURNAL OF CELL BIOLOGY, 1999, 144 (04) :789-801
[2]  
Carreira CM, 2001, CANCER RES, V61, P8079
[3]   Lymphangiogenesis - New mechanisms [J].
Chang, L ;
Kaipainen, A ;
Folkman, J .
LYMPHATIC CONTINUUM: LYMPHATIC BIOLOGY AND DISEASE, 2002, 979 :111-119
[4]   Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity [J].
Chen, L ;
Hamrah, P ;
Cursiefen, C ;
Zhang, Q ;
Pytowski, B ;
Streilein, JW ;
Dana, MR .
NATURE MEDICINE, 2004, 10 (08) :813-815
[5]   Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival [J].
Cursiefen, C ;
Cao, JT ;
Chen, L ;
Liu, Y ;
Maruyama, K ;
Jackson, D ;
Kruse, FE ;
Wiegand, SJ ;
Dana, MR ;
Streilein, JW .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (08) :2666-2673
[6]  
Cursiefen C, 2002, INVEST OPHTH VIS SCI, V43, P2127
[7]   VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment [J].
Cursiefen, C ;
Chen, L ;
Borges, LP ;
Jackson, D ;
Cao, JT ;
Radziejewski, C ;
D'Amore, PA ;
Dana, MR ;
Wiegand, SJ ;
Streilein, JW .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (07) :1040-1050
[8]   Corneal antigen-presenting cells: Diversity, plasticity, and disguise - The Cogan lecture [J].
Dana, MR .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (03) :722-727
[9]  
Dana MR, 1996, INVEST OPHTH VIS SCI, V37, P2485
[10]   Twenty-five-year panorama of corneal immunology - Emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection [J].
Dana, MR ;
Qian, Y ;
Hamrah, P .
CORNEA, 2000, 19 (05) :625-643